The association between XPD Asp312Asn polymorphism and lung cancer risk: a meta-analysis including 16,949 subjects Jian ZhangLi-Xin QiuJian-Hua Chang Original Paper 31 March 2010 Pages: 655 - 660
Prognostic factors in elderly patients with non-small cell lung cancer: a two-center experience U. KefeliS. KayaM. Gumus Original Paper 31 March 2010 Pages: 661 - 666
Genetic polymorphisms in ATM, ERCC1, APE1 and iASPP genes and lung cancer risk in a population of southeast China Qinghua DengLiming ShengShenglin Ma Original Paper 31 March 2010 Pages: 667 - 672
Expression of CDK5/p35 in resected patients with non-small cell lung cancer: relation to prognosis Jun-Li LiuXiao-Yan WangGang Wu Original Paper 31 March 2010 Pages: 673 - 678
Clinical stage of lung cancer revised by accidental pneumothorax and positron emission tomography Qingliang XueJunping SunJianxin Wang Original paper 06 April 2010 Pages: 679 - 681
High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation Chuan-Yong MuJian-An HuangXue-Guang Zhang Original Paper 06 April 2010 Pages: 682 - 688
Comparison of PG-SGA, SGA and body-composition measurement in detecting malnutrition among newly diagnosed lung cancer patients in stage IIIB/IV and benign conditions Rong LiJing WuBaohui Han Original Paper 27 April 2010 Pages: 689 - 696
The relationship between drug exposure and clinical outcomes of non-small cell lung cancer patients treated with gefitinib Yuan-Yuan ZhaoSu LiLi Zhang Original Paper 11 May 2010 Pages: 697 - 702
The value of COX-2 expression in the prognostic parameters of invasive ductal carcinoma of the breast Nagehan Ozdemir BarısıkSevinc Hallac KeserNimet Karadayı Original Paper 31 March 2010 Pages: 703 - 708
P53 gene polymorphisms and breast cancer risk in Arab women Shafika AlawadiLina GhabreauMoussa Alkhalaf Original Paper 05 May 2010 Pages: 709 - 715
Chemotherapy use and risk of bone marrow suppression in a large population-based cohort of older women with breast and ovarian cancer Zhannat NurgalievaChih-Chin LiuXianglin L. Du Original Paper 02 April 2010 Pages: 716 - 725
Clinical outcome of breast cancer patients with N3a (≥10 positive lymph nodes) disease: has it changed over years? Gul BasaranCabuk DevrimSerdar N. Turhal Original Paper 14 April 2010 Pages: 726 - 732
Importance of ATM gene as a susceptible trait: predisposition role of D1853N polymorphism in breast cancer Parvin MehdipourMarzieh MahdaviMorteza Atri Original Paper 16 April 2010 Pages: 733 - 737
Medullary carcinoma of the breast: a population-based perspective Steve R. MartinezShannon H. BealRichard J. Bold Original paper 14 April 2010 Pages: 738 - 744
The CD44+/CD24− phenotype relates to ‘triple-negative’ state and unfavorable prognosis in breast cancer patients Alexandra GiatromanolakiEfthimios SivridisMichael I. Koukourakis Original Paper 20 April 2010 Pages: 745 - 752
Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies Ezzeldin M. IbrahimAbdelaziz Al-Homaidh Original Paper 22 April 2010 Pages: 753 - 765
Dose-dense and dose-intense chemotherapy for small cell ovarian cancer: 2 cases and review of literature Raj Kumar ShrimaliPeter Denzil CorreaNick S. Reed Original Paper 02 April 2010 Pages: 766 - 770
Aromatase inhibitor anastrozole as a second-line hormonal treatment to a recurrent low-grade endometrial stromal sarcoma: a case report Keiko ShojiKatsutoshi OdaYuji Taketani Original Paper 31 March 2010 Pages: 771 - 774
Expression of phosphatase of regenerating liver-3 in squamous cell carcinoma of the cervix Yaxi MaBaizhou Li Original paper 03 April 2010 Pages: 775 - 780
Sensitization of SiHa cell to gemcitabine by CD40 activation and its overexpression in cervical carcinoma Qin HuangQiu-Xia QuXue-Guang Zhang OriginalPaper 14 May 2010 Pages: 781 - 788
Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer Xue-Qin YangYan LiYang Liu Original Paper 07 April 2010 Pages: 789 - 795
Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC) Yu YangJiang ZhuMei Hou Original Paper 17 April 2010 Pages: 796 - 803
Down-regulation of Dicer in hepatocellular carcinoma Jin-Feng WuWei ShenKai-Fu Tang Original Paper 20 April 2010 Pages: 804 - 809
Gallbladder lymphoma Srinivas R. ViswanathanZain KhalpeyStanley W. Ashley Case Report 21 April 2010 Pages: 810 - 812
Anti-cancer effects of 20(S)-protopanoxadiol on human acute lymphoblastic leukemia cell lines Reh and RS4;11 Lihua SunQiong WangHuyong Zheng OriginalPaper 31 March 2010 Pages: 813 - 821
Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: a meta-analysis Jing WangPing ZhanYonggong Yang Original Paper 06 April 2010 Pages: 822 - 828
Post-transplantation lymphoproliferative disorder (PTLD) twenty years after heart transplantation: a case report and review of the literature Petros D. Grivas Original Paper 14 April 2010 Pages: 829 - 834
Knockdown of SOD1 sensitizes the CD34+ CML cells to imatinib therapy Li LiuRenan ChenYingmin Liang Original Paper 21 April 2010 Pages: 835 - 839
Allogeneic haematopoietic stem cell transplantation as a salvage strategy for relapsed or refractory nasal NK/T-cell lymphoma Meng LiChunji GaoWanming Da Original Paper 23 April 2010 Pages: 840 - 845
Effect of heat shock protein-90 (HSP90) and vascular endothelial growth factor (VEGF) on survival in acute lymphoblastic leukemia: an immunohistochemical study Abdullah HacıhanefiogluEmel GonulluCengiz Ercin Original paper 27 April 2010 Pages: 846 - 851
Bax expression remains unchanged following antisense treatment directed against BCL-2 Marvin RubensteinCourtney M. P. HollowellPatrick Guinan Original Paper 27 April 2010 Pages: 852 - 858
Chemotherapy in clear cell sarcoma Robin L. JonesAnastasia ConstantinidouIan R. Judson Original Paper 14 April 2010 Pages: 859 - 863
Alterations of telomere length in human brain tumors Majid KheirollahiMasoud MehrazinParvin Mehdipour Original Paper 07 April 2010 Pages: 864 - 870
Simultaneous over activation of EGFR, telomerase (h TERT), and cyclin D1 correlates with advanced disease in larynx squamous cell carcinoma: a tissue microarray analysis Aristeidis ChrysovergisVasilios G. GorgoulisAspasia Kyroudi Original Paper 07 April 2010 Pages: 871 - 877
Lentivirus-mediated RNAi knockdown of prostate-specific membrane antigen suppresses growth, reduces migration ability and the invasiveness of prostate cancer cells Zhenghui GuoHai HuangJian Huang Original Paper 14 April 2010 Pages: 878 - 887
Natural products and their role in cancer therapy David Siu Original paper 23 April 2010 Pages: 888 - 900
Temozolomide/PLGA microparticles: a new protocol for treatment of glioma in rats Yu-Hui ZhangHe ZhangZhi-Jian Yue Original Paper 16 April 2010 Pages: 901 - 906
Neuritin expression and its relation with proliferation, apoptosis, and angiogenesis in human astrocytoma Lei ZhangYonggeng ZhaoHai-ning Zhen Original Paper 20 April 2010 Pages: 907 - 912
Determination of clonal status of pulmonary sclerosing hemangioma with X-chromosome inactivation mosaicism and polymorphism of phosphoglycerate kinase and androgen receptor genes Li GongKai-Xi RenWei Zhang Original Paper 27 April 2010 Pages: 913 - 918
Role of human papillomavirus in the development of urothelial carcinoma Dilek YavuzerNimet KaradayiDilek Sakirahmet OriginalPaper 29 April 2010 Pages: 919 - 923
